Vincerx Pharma (VINC) Expected to Announce Quarterly Earnings on Friday

Vincerx Pharma (NASDAQ:VINC) is projected to issue its quarterly earnings data before the market opens on Friday, April 4th. Analysts expect the company to announce earnings of ($2.60) per share for the quarter.

Vincerx Pharma Stock Up 9.6 %

NASDAQ VINC opened at $0.63 on Thursday. Vincerx Pharma has a 52 week low of $0.48 and a 52 week high of $136.80. The business has a 50 day moving average price of $1.10 and a 200-day moving average price of $4.89. The company has a market cap of $1.41 million, a price-to-earnings ratio of -0.03 and a beta of 1.43.

Vincerx Pharma Company Profile

Vincerx Pharma, Inc, a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. It is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with hematologic malignancies; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat solid tumors.